RELENOPRIDE HYDROCHLORIDE

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H30ClFN4O4.ClH
Molecular Weight	529.432
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.COC1=CC(N)=C(Cl)C=C1C(=O)NCC2CCN(CC[C@H](OC(N)=O)C3=CC=C(F)C=C3)CC2

InChI

InChIKey=DMJJYQFHCCNBNI-BOXHHOBZSA-N

InChI=1S/C24H30ClFN4O4.ClH/c1-33-22-13-20(27)19(25)12-18(22)23(31)29-14-15-6-9-30(10-7-15)11-8-21(34-24(28)32)16-2-4-17(26)5-3-16;/h2-5,12-13,15,21H,6-11,14,27H2,1H3,(H2,28,32)(H,29,31);1H/t21-;/m0./s1

HIDE SMILES / InChI

Molecular Formula	C24H30ClFN4O4
Molecular Weight	492.971
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27418395 | https://clinicaltrials.gov/ct2/show/NCT02082457 | https://clinicaltrials.gov/ct2/show/NCT01523184 | https://clinicaltrials.gov/ct2/show/NCT01989234

Relenopride (YKP-10811) is a serotonin 4 (5-HT4) receptor agonist that was developed for regulation of gastric motility. It improved antral contractions and accelerated gastric emptying in dogs and had no adverse effects. Phase II clinical trials have investigated the efficacy and safety of relenopride in patients with (chronic and functional) constipation and irritable bowel syndrome (IBD). Relenopride was reported to accelerate gastrointestinal motility and colonic transit and improve bowel functions in patients with functional constipation, compared with placebo.

Originator

Approval Year

PubMed

Title	Date	PubMed
Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation.	2014-12	25316608
The serotonin signaling system: from basic understanding to drug development for functional GI disorders.	2007-01	17241888
Rationale for using serotonergic agents to treat irritable bowel syndrome.	2005-04-01	15790796
Serotonin: a mediator of the brain-gut connection.	2000-10	11051338
Signal transduction pathways for serotonin as an intestinal secretagogue.	1997-10	9366057
Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon.	1996-11	8944700

Substance Class	Chemical Created by `admin` on `Mon Mar 31 20:14:06 GMT 2025` Edited by `admin` on `Mon Mar 31 20:14:06 GMT 2025`
Record UNII	97CC34KNCU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RELENOPRIDE HYDROCHLORIDE

Official Name

English

YKP-10811 HYDROCHLORIDE

Preferred Name

English

Relenopride hydrochloride [WHO-DD]

Common Name

English

BENZAMIDE, 4-AMINO-N-((1-((3S)-3-((AMINOCARBONYL)OXY)-3-(4-FLUOROPHENYL)PROPYL)-4-PIPERIDINYL)METHYL)-5-CHLORO-2-METHOXY-, HYDROCHLORIDE

Systematic Name

English

YKP10811*HCL

Code

English

RELENOPRIDE HYDROCHLORIDE [USAN]

Common Name

English

YKP10811 HYDROCHLORIDE

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C47794